Early Childhood Obesity Programming by Intrauterine Growth Restriction



Status:Not yet recruiting
Conditions:Obesity Weight Loss, Women's Studies
Therapuetic Areas:Endocrinology, Reproductive
Healthy:No
Age Range:Any
Updated:1/20/2018
Start Date:April 1, 2018
End Date:December 31, 2024
Contact:Mamta Fuloria, MD
Email:mfuloria@montefiore.org
Phone:718-904-4105

Use our guide to learn which trials are right for you!

Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction

The molecular mechanisms underlying developmental programming of childhood obesity remain
poorly understood. Here, the investigators address major questions about early childhood
obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR)
newborns who have an increased risk for obesity and other metabolic disorders in adult life.

Epidemiological studies of multiple cohorts suggest an increased risk for obesity,
cardiovascular disease-related death and type 2 diabetes in low birth weight infants.
However, the molecular mechanisms underlying developmental programming of childhood obesity
remain poorly understood. Alterations in DNA methylation during fetal life have been proposed
to be one of the mechanisms that regulate this phenotype. Here, the investigators address
major questions about early childhood obesity programming by studying purified subpopulations
of CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased
risk for obesity and other metabolic disorders in adult life. The investigators will
correlate altered CD3+ T-cell DNA methylation profiles in cord and peripheral blood samples
and functional changes in CD3+ T-cells with adiposity in childhood.

Inclusion Criteria:

- Healthy singleton term IUGR and AGA infants whose mothers are followed by the
Obstetric Department of Montefiore Medical Center and who deliver at the Weiler
Division of Montefiore Medical Center.

Exclusion Criteria:

- Multiple gestation, maternal depression, maternal renal disease, infants in extremis,
Apgar score <7 at 5 min and umbilical artery pH ≤7.25, chromosomal/ congenital
abnormalities, congenital infections and inborn errors of metabolism. We will also
exclude infants born to mothers with a history of maternal smoking in the 2nd and 3rd
trimester of pregnancy and maternal gestational diabetes/T2D.
We found this trial at
1
site
Bronx, New York
?
mi
from
Bronx, NY
Click here to add this to my saved trials